Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for DEUTERIERTE DERIVATE VON RUXOLITINIB
Details for 2018188152
Up to date per 10.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2018188152
Title / Product Name
DEUTERIERTE DERIVATE VON RUXOLITINIB
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2018188152
EP Publication Number
3450434
E-Number
1364302
Language
EN
PCT Number
Publication Date
06.03.2019 A
24.02.2021 B1
Registration Date
24.02.2021
AT Publication Date
15.03.2021
Application Date
14.06.2013
Registration Number
-
Priorities
15.06.2012
US
201261660428 P
02.08.2012
US
201261678795 P
IPC
C07D 487/04 20060101AFI20200619BHEP
Maximum Duration of Protection
14.06.2033
Owner
CoNCERT Pharmaceuticals, Inc.
65 Hayden Avenue, Suite 3000N
Lexington, MA 02421
US
Representative
Representative
Häupl & Ellmeyer KG Patentanwaltskanzlei
Mariahilfer Straße 50 (Kirchengasse 1)
1070 Wien
AT
Inventor
SILVERMAN, I. Robert
36 Orvis Road
Arlington, MA 02474
US
LIU, Julie F.
3 Whitman Circle
Lexington, MA 02420
US
MORGAN, Adam J.
14 Oak Ridge Lane
Ashland, MA 01721
US
PANDYA, Bhaumik
325 Springs Road
Bedford, MA 01730
US
HARBESON, Scott L.
355 Shore Dr
Ellenton, FL 34222-2025
US
Information about Fees
Click here to load the fees